Buy & Sell Abercrombie & Fitch Co. (ANF) – Abercrombie & Fitch Co. Price Today
Aura AI Summary
Key Stats
- $4.07BMarket Cap
- Consumer CyclicalSector
- -31.82%3M Drawdown
- $4.74BEnterprise Value
- -Dividend Yield
- 65 daysTypical Hold Time
Abercrombie & Fitch Co. (ANF) is currently valued at a market capitalization of $4.07B, with an enterprise value of $4.74B. Over the past 52 weeks, Abercrombie & Fitch Co. has traded between a low of $65.61 and a high of $129.85, highlighting its annual price range. Over the past three months, Abercrombie & Fitch Co. has recorded a drawdown of -31.82%, reflecting recent price volatility. On average, investors hold Abercrombie & Fitch Co. for approximately 65 days, indicating typical investor behavior on the platform.
About Abercrombie & Fitch Co.
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumer through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
Most Recent News
Biogen shareholders to receive $18.9M in proposed class action settlement for stock purchases in 2021
A proposed $18.9 million class action settlement has been approved by a U.S. District Court for investors who purchased Biogen Inc. common stock between June 8 and July 12, 2021. The settlement aims to resolve claims against Biogen and certain execut...

Caribou Biosciences CEO to speak at H.C. Wainwright Cell Therapy Conference June 30, 2026
Caribou Biosciences, a clinical-stage CRISPR biopharma company, announced that CEO Rachel Haurwitz will participate in a fireside chat at the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on June 30, 2026. The event highlights Caribou's ...

Kaltura named Representative Vendor in 2026 Gartner Market Guide for Video Platform Services
Kaltura has been recognized as a Representative Vendor in the 2026 Gartner Market Guide for Video Platform Services for the second consecutive year. The company offers AI-driven video platform services that transform video into interactive, intellige...
